4//SEC Filing
Hecht Beth 4
Accession 0001867096-24-000015
CIK 0001867096other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:04 PM ET
Size
5.2 KB
Accession
0001867096-24-000015
Insider Transaction Report
Form 4
Hecht Beth
See Remarks
Transactions
- Award
Common Stock
2024-01-31+750,000→ 1,554,968 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
- [F2]These shares include 7,210 shares that were purchased on June 30, 2023 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001652410
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:04 PM ET
- Size
- 5.2 KB